Additionally, the Ras/Raf/MEK/ERK pathway, which is crucial in the pathophysiology of HCC, is activated by EGF, VEGF, and platelet-derived growth factor [64,65]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.